Surgalign. has been granted a patent for a medical implant featuring a remodelable material pocket designed to house electronic medical devices, such as cardiac rhythm management devices. The implant promotes cellular ingrowth, allowing for the formation of a natural tissue pocket that securely accommodates the device post-implantation. GlobalData’s report on Surgalign gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Surgalign, Prosthetic cardiac valves was a key innovation area identified from patents. Surgalign's grant share as of June 2024 was 58%. Grant share is based on the ratio of number of grants to total number of patents.
Medical implants with remodelable pockets for electronic devices
The granted patent US12042661B2 describes a medical product that features a remodelable material pocket designed to house an implantable electronic medical device, such as a cardiac rhythm management (CRM) device. The pocket consists of two side walls made from multilaminate extracellular matrix materials, which are bonded through a dehydration process known as lyophilization. These walls create an interior space for the device and are sutured together with biodegradable materials at two seams, leaving an open end for device insertion. The design includes a closure flap that can cover the open end, and the extracellular matrix materials are engineered to promote angiogenesis and cellular ingrowth, facilitating the formation of a vascularized tissue pouch around the implanted device.
The patent also outlines methods for treating patients using this remodelable pocket construct. The process involves positioning the electronic medical device within the pocket, securing the open end, and implanting the construct in a subcutaneous location. The extracellular matrix material is designed to be pliable, allowing it to conform to the device while promoting the growth of new vascularized tissue that replaces the matrix over time. This results in a natural tissue pocket that securely accommodates the implantable device, avoiding the formation of fibrotic scar tissue. The patent emphasizes the adaptability of the pocket for various electronic medical devices, including those with non-tissue receptive surfaces, ensuring a secure fit and effective integration with the patient's body.
To know more about GlobalData’s detailed insights on Surgalign, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
